Can I Have Mounjaro? What Decides Whether It's Right for You

Mounjaro (tirzepatide) is licensed in the UK for adults with a BMI of 30 or above, or 27 or above alongside at least one weight-related condition such as high blood pressure or type 2 diabetes.
It is the only dual GIP and GLP-1 receptor agonist licensed for weight management in the UK — a different mechanism from singleagent GLP-1 medicines.
A GPhC-registered Independent Prescriber reviews every consultation personally; suitability is always a clinical decision, not an automated one.
Certain medical histories (including a personal or family history of medullary thyroid carcinoma, or active pancreatitis) require careful discussion before treatment can proceed.

Whether Mounjaro is suitable for you depends on a handful of clinical factors — mainly your BMI, your health history, and any medicines you already take. It is a prescription-only medicine, so a registered prescriber makes that call after a proper assessment, not a checklist on a website. Here is what goes into that decision, and what to do next.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

The factors a prescriber weighs when you ask about Mounjaro

Does your BMI put you in range?

The licensed threshold is a BMI of 30 or above, or 27 or above if you have at least one condition that is made worse by excess weight. Those conditions include type 2 diabetes, high blood pressure, raised cholesterol, obstructive sleep apnoea, and similar. You do not need all of them; one is enough to bring the lower BMI threshold into play.

For some ethnic backgrounds (South Asian, Chinese, other Asian, Middle Eastern, Black African or African-Caribbean) NICE and NHS guidance recognises that health risk increases at a lower BMI, so thresholds are typically set 2.5 kg/m² lower. The NICE technology appraisal for tirzepatide (TA1026) is explicit on this point.

BMI is a starting point, not the whole picture. A prescriber looks at the number alongside everything else. Hitting the threshold is necessary but not on its own sufficient, the full clinical assessment is what matters. If you want a quick sense of where you stand, the NHS BMI calculator gives you a reliable baseline before you begin a consultation.

What your health history tells a prescriber

Some conditions make Mounjaro a straightforward clinical fit; others need more careful thought. Type 2 diabetes, high blood pressure, and high cholesterol are all conditions the medicine is licensed to treat or help alongside, they may actually strengthen the case for it.

A history of pancreatitis is different. Acute pancreatitis is a known, infrequent but serious risk with GLP-1 class medicines, and a prescriber will explore that history before proceeding. The same applies to a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia type 2. These are not automatic barriers to every weight-management treatment, but they do require a proper conversation.

If you live with IBS or a similar gastrointestinal condition, that is worth raising too, how Mounjaro interacts with conditions like IBS is something our prescribers are asked about regularly, and the answer depends on the individual. Other medicines you take matter as well. Tirzepatide slows gastric emptying, which can affect how quickly oral medicines are absorbed, and if you are wondering whether Mounjaro contains tirzepatide and what that means in practice, our dedicated page explains the relationship clearly.

Pregnancy, breastfeeding and other situations where Mounjaro is not suitable

Mounjaro is not recommended during pregnancy or while breastfeeding, and it is not advised if you are actively trying to conceive. The medicine is not licensed for anyone under 18. These are firm boundaries, not grey areas.

If you use oral contraceptives, there is a specific point worth knowing. Women on the pill are advised to add a barrier method for the first four weeks of Mounjaro treatment and for four weeks after each dose increase, because the slower gastric emptying can reduce how reliably the pill is absorbed. NHS England's guidance on weight-management injections covers this, and the same applies to transdermal HRT, a prescriber or GP can advise on switching to patches or gels if oral HRT is part of your current routine.

If any surgery is planned, your anaesthetist and surgical team need to know you are taking Mounjaro. That conversation should happen well in advance, not on the day.

So, can you have Mounjaro, and how do you find out for certain?

The honest answer is that nobody can tell you definitively without a clinical assessment. What this page can tell you is that the eligibility criteria are genuinely broad: most adults with a BMI of 30 or above, or 27 or above with a relevant condition, fall within the licensed range. The medicine has been through extensive trials (the weight-loss results seen in those trials are substantial) and NICE has recommended it for NHS use, which means regulators have already judged the evidence strong enough to support widespread prescribing.

What a prescriber is really doing is checking your individual circumstances against that picture. It takes a few minutes with a properly structured consultation. At nume, that means a GPhC-registered Independent Prescriber reads your answers the same day, not software, not an automated filter. If you order before noon on a working day and are approved, your treatment leaves our pharmacy the same afternoon and arrives with DPD the next working day. More detail on what the treatment process involves is on our consultation and treatment page.

If you are still weighing up your options more broadly, our weight-loss treatment overview sets out how Mounjaro compares to other licensed approaches. And if cost is part of your thinking, an honest breakdown of what private treatment involves is on our Mounjaro cost guide, worth reading before you decide where to go. It is also worth knowing that taking a week off Mounjaro and taking a longer break from Mounjaro are questions our prescribers regularly help patients think through, so do raise either if your circumstances make continuity difficult.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions